Neuroreport · 2000 · 15 citations · 4 references
MedicineNeurobiologyNeuroscienceApoptosisNeurodegenerationNeuropharmacologyDopaminergic PharmacologyDrug-induced NeurotoxicityNeurodegenerative DiseasesNeuroprotectionParkinson DiseaseParkinsonian DisordersApoptotic Morphological ChangesApoptotic MorphologyCell Death AssaysDopaminergic NeurodegenerationDopaminergic Neuron DeathNeural Cell DeathParkinson’s Disease TreatmentTransplantation
Adrenal chromaffin cell (ACC) transplantation has been considered as one of the therapeutic strategies for Parkinson disease (PD). This strategy involves the administration of L-DOPA, although in reduced doses, to ACC-transplanted patients. Using cytochemical and morphological methods, we examined the effects of clinically applicable concentrations of L-DOPA on cultured chromaffin cells. We found an increase of cell death in both necrotic and apoptotic patterns. These data suggest that therapeutic preventive measures during ACC transplantation processes for PD should be taken.
4